5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
C159H188F2N24O16 — CID 158850894
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPAC5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
SMILESCC1(C)CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1(F)C[C@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1CN(CC2CCC2)C(=O)c2cc(COc3ccccc3)nn21.C[C@@H]1Cn2nc(COc3ccccc3)cc2C(=O)N1CC1CCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1Cc2ccccc2C1.O=C1c2cc(COc3ccccc3)nn2CCN1CC1CCCCC1
InChIInChI=1S/C22H21N3O2.C21H27N3O2.3C20H25N3O2.2C19H23N3O2.C18H19F2N3O2/c26-22-21-14-18(15-27-20-8-2-1-3-9-20)23-25(21)11-10-24(22)19-12-16-6-4-5-7-17(16)13-19;1-21(2)10-8-17(9-11-21)23-12-13-24-19(20(23)25)14-16(22-24)15-26-18-6-4-3-5-7-18;1-15-7-9-17(10-8-15)22-11-12-23-19(20(22)24)13-16(21-23)14-25-18-5-3-2-4-6-18;24-20-19-13-17(15-25-18-9-5-2-6-10-18)21-23(19)12-11-22(20)14-16-7-3-1-4-8-16;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-11-22-18(19(23)21(14)12-15-6-5-7-15)10-16(20-22)13-24-17-8-3-2-4-9-17;1-14-11-21(12-15-6-5-7-15)19(23)18-10-16(20-22(14)18)13-24-17-8-3-2-4-9-17;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15/h1-9,14,19H,10-13,15H2;3-7,14,17H,8-13,15H2,1-2H3;2-6,13,15,17H,7-12,14H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14-15H2;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2*2-4,8-10,14-15H,5-7,11-13H2,1H3;2-4,7-8,12H,5-6,9-11H2,1H3/t;;;;;14-;;12-,18?/m.....1.0/s1
InChIKeyIZKYQIVZKJVHLV-XAAFLRJGSA-N
MW2729.40 g/mol
LogP26.80
Rot. Bonds36
About 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (PubChem CID 158850894) has the molecular formula C159H188F2N24O16 and a molecular weight of 2729.40 g/mol. Its IUPAC name is 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
Molecular Properties
| Compound Name | 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
|---|---|
| PubChem CID | 158850894 |
| Molecular Formula | C159H188F2N24O16 |
| Molecular Weight | 2729.40 g/mol |
| Exact Mass | 2727.46 |
| IUPAC Name | 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
| SMILES | CC1(C)CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1(F)C[C@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1CN(CC2CCC2)C(=O)c2cc(COc3ccccc3)nn21.C[C@@H]1Cn2nc(COc3ccccc3)cc2C(=O)N1CC1CCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1Cc2ccccc2C1.O=C1c2cc(COc3ccccc3)nn2CCN1CC1CCCCC1 |
| InChI | InChI=1S/C22H21N3O2.C21H27N3O2.3C20H25N3O2.2C19H23N3O2.C18H19F2N3O2/c26-22-21-14-18(15-27-20-8-2-1-3-9-20)23-25(21)11-10-24(22)19-12-16-6-4-5-7-17(16)13-19;1-21(2)10-8-17(9-11-21)23-12-13-24-19(20(23)25)14-16(22-24)15-26-18-6-4-3-5-7-18;1-15-7-9-17(10-8-15)22-11-12-23-19(20(22)24)13-16(21-23)14-25-18-5-3-2-4-6-18;24-20-19-13-17(15-25-18-9-5-2-6-10-18)21-23(19)12-11-22(20)14-16-7-3-1-4-8-16;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-11-22-18(19(23)21(14)12-15-6-5-7-15)10-16(20-22)13-24-17-8-3-2-4-9-17;1-14-11-21(12-15-6-5-7-15)19(23)18-10-16(20-22(14)18)13-24-17-8-3-2-4-9-17;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15/h1-9,14,19H,10-13,15H2;3-7,14,17H,8-13,15H2,1-2H3;2-6,13,15,17H,7-12,14H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14-15H2;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2*2-4,8-10,14-15H,5-7,11-13H2,1H3;2-4,7-8,12H,5-6,9-11H2,1H3/t;;;;;14-;;12-,18?/m.....1.0/s1 |
| InChIKey | IZKYQIVZKJVHLV-XAAFLRJGSA-N |
| XLogP | 26.80 |
| TPSA | 378.88 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 201 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2729.40 |
| LogP ≤ 5 | 26.80 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
What is the IUPAC name of 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The IUPAC name of 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (CID 158850894) is 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
What is the SMILES notation for 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The canonical SMILES for 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one is CC1(C)CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1(F)C[C@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CCC(N2CCn3nc(COc4ccccc4)cc3C2=O)CC1.CC1CN(CC2CCC2)C(=O)c2cc(COc3ccccc3)nn21.C[C@@H]1Cn2nc(COc3ccccc3)cc2C(=O)N1CC1CCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1Cc2ccccc2C1.O=C1c2cc(COc3ccccc3)nn2CCN1CC1CCCCC1.
What is the InChIKey of 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The InChIKey is IZKYQIVZKJVHLV-XAAFLRJGSA-N. The full InChI is InChI=1S/C22H21N3O2.C21H27N3O2.3C20H25N3O2.2C19H23N3O2.C18H19F2N3O2/c26-22-21-14-18(15-27-20-8-2-1-3-9-20)23-25(21)11-10-24(22)19-12-16-6-4-5-7-17(16)13-19;1-21(2)10-8-17(9-11-21)23-12-13-24-19(20(23)25)14-16(22-24)15-26-18-6-4-3-5-7-18;1-15-7-9-17(10-8-15)22-11-12-23-19(20(22)24)13-16(21-23)14-25-18-5-3-2-4-6-18;24-20-19-13-17(15-25-18-9-5-2-6-10-18)21-23(19)12-11-22(20)14-16-7-3-1-4-8-16;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-11-22-18(19(23)21(14)12-15-6-5-7-15)10-16(20-22)13-24-17-8-3-2-4-9-17;1-14-11-21(12-15-6-5-7-15)19(23)18-10-16(20-22(14)18)13-24-17-8-3-2-4-9-17;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15/h1-9,14,19H,10-13,15H2;3-7,14,17H,8-13,15H2,1-2H3;2-6,13,15,17H,7-12,14H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14-15H2;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2*2-4,8-10,14-15H,5-7,11-13H2,1H3;2-4,7-8,12H,5-6,9-11H2,1H3/t;;;;;14-;;12-,18?/m.....1.0/s1.
What are the key properties of 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one has a molecular weight of 2729.40 g/mol, XLogP of 26.80, 36 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(cyclobutylmethyl)-7-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;(6R)-5-(cyclobutylmethyl)-6-methyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclohexylmethyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,3-dihydro-1H-inden-2-yl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4,4-dimethylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[[(1S)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylcyclohexyl)-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one is sourced from PubChem (CID 158850894), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158850894 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.